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The human ZFAT gene encodes a 1243-amino-acid protein containing one AT hook and 18 C2H2 zinc finger domains, which are highly
conserved among ZFAT orthologues from fish to mammalian species. Consistent with the presence of multiple predicted nuclear localization
signals, endogenous ZFAT protein was found to be localized to the nucleus. In the mouse tissues examined by Western blotting, ZFAT was found
to be expressed in thymus, spleen, and lymph nodes, but not in other tissues, including bone marrow. Furthermore, ZFAT protein was found to be
up-regulated during the transition from CD4-CD8- to CD4+CD8+ thymocytes and to be expressed only in B and T lymphocytes in peripheral
lymphoid tissues. Expression array analyses demonstrated that genes that are down-regulated upon ZFAT overexpression in mouse Ba/F3 cells are
significantly enriched for those functionally related to immune responses. These results suggest that ZFAT functions as a critical transcriptional
regulator in B and T lymphocytes.
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largest classes of protein superfamily in the mammalian genome
and are best characterized as transcriptional regulators in a
variety of cellular activities [1]. The C2H2 zinc finger is the
most common form among over 80 subclasses of zinc finger
domains (the list of Pfam entries is available at http://pfam.
sanger.ac.uk/). One zinc finger, composed of 25-30 amino acid
residues, recognizes the major groove of the double-helix DNA
and interacts with 3 bp. Tandem repeats of multiple zinc fingers
determine the sequence specificity of DNA recognition [1]. In
the SMART database (http://smart.embl-heidelberg.de/), 789
human and 760 mouse proteins with C2H2 zinc finger domains
are registered. While many of these zinc finger proteins have⁎ Corresponding author. Fax: +81 92 864 3865.
E-mail address: sshirasa@fukuoka-u.ac.jp (S. Shirasawa).
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doi:10.1016/j.ygeno.2008.01.009already been well characterized, a large portion of them are still
functionally unknown. Assignment of functional information to
each of uncharacterized zinc finger proteins certainly facilitates
the understanding of their roles in various cellular processes and
potential relevance to human diseases.
Autoimmune thyroid disease (AITD), including Graves'
disease (GD) and Hashimoto thyroiditis (HT), is caused by an
immune response to self-thyroid antigens and affects up to 2-5%
of the general population [2]. GD is characterized by the
production of thyroid-stimulating hormone receptor-stimulating
antibodies, leading to hyperthyroidism, whereas HT is char-
acterized by the apoptosis of the thyrocytes, resulting in hypo-
thyroidism [3,4]. Twin studies and familial aggregation have
clearly indicated that AITD is caused by a combination of both
environmental and genetic factors [5,6]. Through linkage and
association analyses on a cohort of Japanese AITD patients
[7,8], we have previously identified ZFAT (zinc-finger gene in
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both GD and HT [8].
The human ZFAT gene, also known as ZNF406, encodes a
1243-amino-acid residue protein that contains one AT hook
and 18 C2H2 zinc-finger domains. The AT-hook domain is
composed of a conserved 9-amino-acid DNA-binding motif
containing a GRP consensus sequence [9]. It was originally
identified in the HMG-I(Y) protein and has been found in a
wide variety of DNA binding proteins. It has been shown to be
necessary and sufficient to bind to the minor groove of AT-tract
DNA [10,11]. These domain features indicate the possibility
that ZFAT protein binds to DNA and functions as a trans-
criptional regulator. Here, we show that ZFAT protein is
expressed in B and T lymphocytes in mouse and that ZFAT
regulates immune-related genes functionally important for im-
mune responsiveness.
Results and discussion
Evolutionary conservation of domain contents of ZFAT
The human ZFAT protein contains an AT-hook domain at the
N-terminal region and 18 C2H2-type zinc finger domains. Eight
zinc finger domains (and a zinc finger-like domain) are located
in the N-terminal-half region and the remaining 10 zinc finger
domains in the C-terminal-half region (Fig. 1A). To observe the
evolutionary conservation of ZFAT protein structure in multiple
lineages, we collected nucleotide and protein sequences from a
wide range of organisms using genome annotation databases
and the BLAST programs (NCBI). Based on the similarity of
the deduced protein sequences and the conservation of exon-
intron structures of the collected gene sequences, we concluded
that mammalian species, chicken, lizard, frog, and at least some
of teleost fish species contain a gene orthologous to the human
ZFAT gene. No apparent paralogous gene with ZFATwas found
in these vertebrate species. A multiple alignment of protein
sequences from human, mouse, rat, chicken, Xenopus, and
zebrafish was generated for sequence comparisons (Fig. 1B).
The overall content, the positions, and the sequences of the zinc
finger and AT-hook domains were well conserved among the six
species. The perfect conservation between human and zebrafish
was observed for the second zinc finger and the AT-hook
domains. As for the regions outside of the known domains,
several evolutionarily highly conserved regions (highlighted in
pink in Fig. 1B) and one continuous highly diverse region
between zinc fingers 8 and 9 were observed.Fig. 1. (A) Domain/motif content of the human ZFAT protein. The positions of an AT
18), and three predicted classical NLSs [16] are shown as blue, light green, green, an
from six species. Six protein sequences (NP_065914.2 (human), NP_941046.1 (mou
XP_694698.2 (zebrafish)) were aligned using ClustalW (http://www.ebi.ac.uk/Tools
symbols: “⁎” (identical in all sequences), “:” (conserved substitutions), and “.” (semi
green) were defined by the pattern of #-X-C-X(1-5)-C-X3-#-X5-#-X2-H-X(3-6)-[H/C
residues, and # are those that are important for the stable fold (Pfam Accession No.
outside the clusters of zinc finger domains (#2-8 and #9-18) are highlighted in pink. T
bars, respectively.PSORTII programs (http://psort.nibb.ac.jp/form2.html) pre-
dicted three classical and three bipartite nuclear localization signals
(NLSs) in the human ZFAT protein sequence. The predicted
classical NLSs are 71KRKR74 overlapped with the AT-hook
motif (KRKRGRPKG), 171KRPR174, and 379PQDKKVK385. The
predicted bipartite NLSs are 159KKCKEDDREKASKRPRS175,
399KRQLLYDCHICERKFKN415, and 452RKHPFVYVCAVCRK
KFV468. All six NLSs are mostly evolutionarily conserved and
positioned in the N-terminal-half region. Consistent with this
prediction, when the ZFAT protein with a HA tag at its C-terminus
was transiently expressed in HEK293 cells, the protein was found to
be predominantly localized to the nucleus (data not shown).
These observations indicate that ZFAT likely binds to DNA
through its evolutionarily conserved AT-hook and at least some
of the C2H2 zinc-finger domains and functions as a transcrip-
tional regulator in the nucleus. The conserved regions outside
the known domains may be involved with transactivation/re-
pression and/or protein-protein interactions and should be fur-
ther characterized in future studies. The evolutionarily diverse
region may function as a spacer to separate two zinc finger
clusters, which are potentially functionally distinct from each
other as was shown in previously well-characterized multi-zinc
finger-containing proteins such as the Ikaros family [14] and
CTCF [15]. We are currently performing chromatin immuno-
precipitation analysis to identify direct ZFAT target sites in the
mouse genome.
Expression pattern of the endogenous ZFAT protein in mouse
tissues and purified lymphocytes
We raised rabbit polyclonal antiserum against a 164-residue
C-terminal fragment of the mouse ZFAT protein. The polyserum
detected a major band at approximately 180 kDa on mouse Ba/
F3 and other cell lines inWestern blot analysis (data not shown).
The intensity of the detected band was significantly decreased
on the Ba/F3 cells treated with small inhibitory RNAs (siRNAs)
targeted to Zfat, compared to the Ba/F3 cells treated with
scramble control RNAs, indicating that the detected band by
the polyserum is specific to ZFAT protein (Fig. 2A). We then
determined the tissue and cell-type distribution of ZFAT protein.
In the nine tissues from 6-week-old male C57BL6/J mice tested,
the ZFAT protein was detected in spleen and thymus, but not in
other tissues, including bone marrow (Fig. 2B). Subsequently,
we examined MACS-selected lymphocytes from immune
tissues of C57BL6/J mice (6-week-old, male) to determine the
cell-type distribution of the ZFAT protein. Among lymphocytes-hook motif, a zinc finger-like domain, C2H2 zinc finger domains (Zf_C2H2 #1-
d red rectangles, respectively. (B) The multiple alignment of ZFAT orthologues
se), XP_343256.2 (rat), XP_418429.2 (chick), NP_001073041.1 (Xenopus), and
/clustalw/index.html). The degree of conservation is denoted by the following
conserved substitutions). Each of the C2H2 zinc finger domains (highlighted in
], where X can be any amino acid, numbers in parentheses indicate the number of
PF00096, http://www.sanger.ac.uk/Software/Pfam/). Highly conserved regions
he positions of predicted classical and bipartite NLSs are shown by red dots and
Fig. 2. Western blot analyses for (A) siRNA-treated and control mouse Ba/F3 cells, (B) nine types of tissues from 6-week-old male C57BL/6J mice, (C) mouse
peritoneal macrophages and MACS-selected lymphocytes isolated from mouse spleen and lymph nodes, (D) MACS-selected lymphocytes isolated from mouse
thymus, and (E) cytoplasmic and nuclear fractions of Ba/F3 cells. Affinity-purified anti-ZFAT antibody was used to detect endogenous ZFAT protein. Western blotting
using anti-actin antibody or anti-ERK antibody was performed as loading control (A-E).
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in CD19+, CD4+, and CD8+ lymphocytes, but undetectable
in CD11b+ lymphocytes (Fig. 2C). ZFAT protein was also
undetectable in mouse peritoneal macrophages. These results
demonstrated that ZFAT protein is predominantly expressed in
B and T lymphocytes but not in other cell types such as mono-
cytes and macrophages in secondary lymphoid tissues. To as-
sess the expression pattern of ZFAT protein during thymocyte
differentiation, we separated thymocytes into four fractions
(CD4-CD8-, CD4+CD8+, CD4+CD8-, and CD4-CD8+) and
subjected them to Western blot analysis. ZFAT was found to be
expressed in immature CD4-CD8- double-negative cells at a
low level and expressed at much higher levels in the other three
fractions (Fig. 2D). To determine the subcellular localization of
endogenous ZFAT protein, cytoplasmic and nuclear fractions
from Ba/F3 cells were analyzed. Consistent with the aforemen-
tioned result of the transient expression assay, the endogenous
ZFAT protein was detected in the nuclear fraction, although a
significant amount of ZFAT protein was also detected in the
cytosolic fraction (Fig. 2E). The nuclear-specific detection of
CREB and the cytoplasmic-specific detection of c-Raf and PDK
indicate that the subcellular fractionation was performed
successfully.
Taken together with the fact that ZFAT protein was
undetectable in bone marrow, where immature B lymphocytes
and thymus-seeding progenitor cells reside, the expression level
of ZFAT protein seems to be kept low at early stages and to
become elevated at later stages during the differentiation of the
B and T cell lineages. At the mRNA level, ZFAT expression
could be detected in a wide variety of tissues at various levels
[8]. Therefore, it was intriguing that the expression of mouse
ZFAT protein was found to be limited to spleen, lymph nodes,
and thymus. This observation indicates the possibility that a
posttranslational regulation mechanism(s) to stabilize or to
degrade the ZFAT protein exist in these immune tissues. Ourresults imply that ZFAT functions as a transcriptional regulator
during B and T lymphocyte differentiation.
Global gene expression analysis using expression microarrays
As an approach to understanding the immunological func-
tions of ZFAT, we examined the impact of ZFAToverexpression
on the global gene expression in a mouse immune cell line, Ba/
F3. Three Ba/F3 clones that stably express ZFAT-HA protein, as
well as three control clones carrying an empty vector, were
isolated and subjected to microarray-based expression analy-
ses. The ectopic expression of ZFAT-HA was confirmed by
quantitative RT-PCR (data not shown) and Western blot ana-
lysis (Fig. 3A). We initially employed CodeLink UniSet Mouse
20K bioarrays to identify genes that were differentially ex-
pressed upon ZFAT overexpression. We used two filtering
methods, volcano plots and Venn diagrams, with two different
thresholds for each method to select differentially expressed
genes. The number of the genes selected from the 12,982
“present/good” genes varied from 805 (6.2%) to 50 (0.39%)
among four types of the selections performed (Table 1). The list
of the 216 genes (1.66%) selected by volcano plot filtering
(fold change N2.0 and t test pb0.1), composed of 171 down-
regulated and 45 up-regulated genes, is provided as Supple-
mentary Tables 1 and 2. Among the 50 differentially expressed
genes selected using Venn diagrams with 2.0-fold change as the
threshold, 24 genes were subjected to quantitative RT-PCR to
validate the CodeLink data. Up- or down-regulation identified
by the CodeLink arrays was reproduced for the majority of the
genes examined (Fig. 3B and Supplementary Tables 1 and 2).
Furthermore, we analyzed the same materials using the
GeneChip Mouse Genome 430 2.0 array (Affymetrix) and
extracted differentially expressed genes from the 20,218 “pre-
sent/marginal” genes (Table 1). The number of differentially
expressed genes varied from 219 (1.09%) to 24 (0.12%). The
Fig. 3. (A)Western blot analysis using an anti-HA antibody (3F10) on ZFAT-HA
stable transformants and control Ba/F3 clones. (B) The expression levels of 24
differentially regulated genes in ZFAT-HA stable transformants (gray bars)
relative to those in control Ba/F3 clones (open bars) measured by quantitative
RT-PCR. Three genes (Ctla2, Hhex, and Eomes) were identified as up-regulated,
and the other genes as down-regulated, by the CodeLink arrays.
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change N1.5 and t test pb0.1), composed of 120 down-re-
gulated and 99 up-regulated genes, is provided as Supplemen-
tary Tables 3 and 4. Comparison of the number of differentially
expressed genes between CodeLink and Affymetrix datasets
with the same filtering condition revealed that 3.2-6.3 times
higher percentage of the genes were detected in the CodeLink
dataset than in the Affymetrix dataset. This tendency may
have originated from the lower noise levels of the CodeLinkTable 1
Number of genes differentially expressed upon ZFAT overexpression identified usin
Platform Expression No. of genes (%)
Volcano plot
Fold change N1.5 (p
CodeLink UniSet Mouse 20K bioarray
(12,982 genes)
Down 467 (3.60%)
Up 338 (2.60%)
Total 805 (6.20%)
Affymetrix GeneChip Mouse Genome 430 2.0
(20,018 genes)
Down 120 (0.60%)
Up 99 (0.49%)
Total 219 (1.09%)array compared to the Affymetrix GeneChip at middle to low
expression ranges [18].
To search for common functional features among these
ZFAT-regulated genes, we performed Gene Ontology (GO)
analysis using the GeneSpring software. To compare the results
between CodeLink and Affymetrix datasets, the 216 differen-
tially expressed genes from the CodeLink data and the 219
genes from the Affymetrix data (Table 1) were subjected to GO
analysis, since these two sets are almost the same in the number
of genes detected. Interestingly, GO terms showing statistically
significant enrichment (pb10-5) were identified only in the
down-regulated genes in both datasets (Tables 2 and 3). All GO
terms identified are related to keywords such as “immune/
inflammatory response,” “response to external stimulus,” or
“chemotaxis.” Such GO terms were also found to be associated
with the sets of down-regulated genes selected by other criteria
(Table 1) (data not shown). Although only 21 genes (underlined
in Supplementary Tables 1-4) are common between 216 and
219 differentially expressed genes identified by two employed
platforms, GO analysis captured extremely similar functional
signatures between the two datasets. This is consistent with
the previous observation that enriched GO terms showed
the highest reproducibility in the systematic comparisons of
the datasets acquired using different microarray platforms for
standard RNA samples [17]. The down-regulated genes to
which the enriched GO terms listed in Tables 2 and 3 are
assigned (shown in boldface in Supplementary Tables 1-4)
include cell surface receptor genes (such as Fcgr2b, Ccr1,
Ccr2, C3ar1, Fcrg2b, and Olr1), ligand genes (such as Il4,
Il15, Il1rn, Mst1, Ccl6, Ccl9, and Cxcl15), and secreted protein-
coding genes (such as Prg2, Ngp, S100b, S100a8, S100a9,
Pglyrp1, Cfp, and Spp1). The encoded proteins by these genes
are all associated with cell membrane and/or extracellular
matrix, and many of those are involved in immune cell sig-
naling. Therefore, down-regulation of these genes by ZFAT
overexpression may make Ba/F3 cells inert against external
immune stimuli.
In summary, we have revealed that ZFAT protein is expres-
sed exclusively in B and T lymphocytes in immune tissues in
differentiation stage-specific manners and that overexpression
of ZFAT in Ba/F3 cells mainly down-regulates a subset of genes
functionally important in immune response. Since ZFAT was
originally identified as an AITD susceptible gene, our findingsg two array platforms
Venn diagram
b0.1) Fold change N2.0 ( pb0.1) Fold change N1.5 Fold change N2.0
171 (1.32%) 152 (1.17%) 46 (0.35%)
45 (0.35%) 44 (0.34%) 4 (0.03%)
216 (1.66%) 196 (1.51%) 50 (0.39%)
42 (0.21%) 41 (0.20%) 22 (0.11%)
21 (0.10%) 8 (0.04%) 2 (0.01%)
63 (0.31%) 49 (0.24%) 24 (0.12%)
Table 2
Gene Ontology terms enriched in ZFAT-regulated genes identified using
CodeLink arrays
Category Genes in
category
(10,941)
Down-regulated
(125 genes)
Up-regulated
(34 genes)
n % n % p value n % p value
GO:6955, immune response 560 5.1 21 16.8 1.29×10−6 3 8.8 0.25
GO:6952, defense response 639 5.8 22 17.6 2.88×10−6 2 5.9 0.60
GO:9607, response to biotic
stimulus
670 6.1 22 17.6 6.20×10−6 2 5.9 0.63
Of 171down-regulated and 45 up-regulated genes, 125 and 34, respectively,
were found to have GO term annotations and were subjected to the GO term
enrichment analysis.
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related diseases.
Materials and methods
Cloning of full-length mouse Zfat cDNA
A 1.6-kb mouse Zfat cDNA fragment was amplified by a PCR primer set for
human ZFAT (5'-ACCAGTTCCATCAACCAGAGC-3' and 5'-AAAGCTG-
CAAACAGGACACTT-3') using mouse small intestine cDNA as template. 5'-
and 3'-RACE was performed using the SMART RACE cDNA amplification kit
(Clontech) to obtain full-length cDNA. The sequence of the amplified cDNA
fragments by RACE contained the first Met and the termination codon. The
complete open reading frame sequence of Zfat (GenBank Accession No.
EU221277) was amplified by PCR and cloned.
Cell culture and siRNA
Ba/F3 cells were cultured at 37°C with 5% CO2 in RPMI 1640 containing
10% fetal calf serum and 10% WEHI3B conditioned supernatant. Ba/F3 cells
were transfected with a siRNA by electroporation. Two distinct siRNAs were
designed to target the mouse Zfat mRNA sequence (nt 231-255 and 740-764 of
GenBank Accession No. NM_198664). Scrambled RNAs containing the same
number of each nucleotide as the siRNAs targeted to Zfat were used as controls.
The following siRNA duplexes were used: Zfat #1, 5'-AAACGUGGGUCAC-
GAGUUCUGACUG-3' and 5'-CAGUCAGAACUCGUGACCCACGUUU-3';
scramble RNA #1, 5'-AAAGACGUGGGUCACGAGUUCUCUG-3' and 5'-Table 3
Gene Ontology terms enriched in ZFAT-regulated genes identified using GeneChip
Category Genes in category (20,834)
n %
GO:9605, response to external stimulus 792 3.8
GO:9613, response to pest, pathogen, or parasite 525 2.5
GO:43207, response to external biotic stimulus 538 2.6
GO:6954, inflammatory response 212 1.0
GO:6955, immune response 854 4.1
GO:6952, defense response 1022 4.9
GO:9607, response to biotic stimulus 1052 5.1
GO:42330, taxis 157 0.8
GO:6935, chemotaxis 157 0.8
GO:9611, response to wounding 382 1.8
GO:42221, response to chemical stimulus 435 2.1
Of 120 down-regulated and 99 up-regulated genes, 56 and 43, respectively, were fou
analysis.CAGAGAACUCGUGACCCACGUCUUU-3'; Zfat #2, 5'-UUCAUGAGCA-
GUUAAGACCACGCUG-3' and 5'-CAGCGUGGUCUUAACUGCUCAU-
GAA-3'; scramble RNA #2, 5'-UUCGCAGAGUUGACGAAUACCACUG-3'
and 5'-CAGUGGUAUUCGUCAACUCUGCGAA-3'.
Isolation of ZFAT-HA stable transformants
A 3.7-kb fragment containing the full-length mouse Zfat coding region (nt 1-
3711 ofGenBankAccessionNo. EU221277), a HA-tag sequence at theC-terminus
of ZFAT, and a stop codon right after the HA-tag sequence was cloned into an
expression vector carrying the CMVenhancer-promoter. Ba/F3 cells (5×106) were
transfected with 15 µg of the plasmid DNA by electroporation. The pulsed cells
were disseminated into 96-well plates and incubated in the selection medium
supplemented with 1 mg/ml G418. The expression level of mouse ZFAT-HAwas
tested byWestern blot using anti-HA antibody (3F10;Roche). Stable transformants
expressing ZFAT-HAwere subcloned by limiting dilution.
Generation of anti-ZFAT polyserum and Western blot analysis
Recombinant mouse ZFAT fragment (amino acid residues 1074-1237) was
expressed as a GST fusion protein using the pGEX6P-1 vector (GE Healthcare).
The fusion protein was soluble in nondenaturing buffer and was purified with
glutathione-Sepharose4B. Antiserum was obtained by injecting the recombinant
ZFAT protein into a Japanese White rabbit followed by booster injection.
Antiserum was purified with an affinity column prepared by cross-linking the
recombinant protein to CNBr-activated Sepharose 4B. Positive selection or
depletion of a specific type of lymphocyte was carried out using MACS
microbeads coated with a specific monoclonal antibody (Miltenyi Biotec).
Tissues from C57BL/6J mice, purified lymphocytes, or cultured cells were lysed
in RIPA buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% NP-40, 0.5%
deoxycholate, 0.1% SDS, protease inhibitor cocktail (Roche)) and subjected to
Western blotting as described previously [12]. Antibodies used were affinity-
purified anti-ZFATantibody (dilution 1:1000), anti-ERK1 antibody (K-23; Santa
Cruz Biotechnology; 1:1000), anti-CREB antibody (Cell Signaling; 1:500), and
anti-actin antibody (H-300; Santa Cruz Biotechnology; 1:1000).
Expression array analyses and quantitative RT-PCR
Total RNA was extracted from three ZFAT-HA stable transformants and
three control Ba/F3 clones using the Qiagen RNeasy kit. Preparation of
biotinylated antisense cRNA, hybridization to the CodeLink UniSet Mouse 20K
bioarray (GE Healthcare) and to the GeneChip Mouse Genome 430 2.0 array
(Affymetrix), washing, scanning, and data processing were performed according
to the manufacturers’ instructions and as described previously [13]. Output files
were then loaded into GeneSpring v7.3 (Agilent Technologies) with per-chiparrays
Down-regulated (56 genes) Up-regulated (43 genes)
n % p value n % p value
16 28.6 1.76×10−10 1 2.3 0.81
13 23.2 1.06×10−9 1 2.3 0.67
13 23.2 1.43×10−9 1 2.3 0.68
9 16.1 5.15×10−9 0 0.0 1.00
14 25.0 4.21×10−8 2 4.7 0.53
15 26.8 5.40×10−8 3 7.0 0.36
15 26.8 7.89×10−8 3 7.0 0.37
7 12.5 2.12×10−7 0 0.0 1.00
7 12.5 2.12×10−7 0 0.0 1.00
9 16.1 7.86×10−7 0 0.0 1.00
9 16.1 2.29×10−6 1 2.3 0.60
nd to have GO term annotations and were subjected to the GO term enrichment
457M. Koyanagi et al. / Genomics 91 (2008) 451–457normalization to the 50th percentile and per-gene normalization to the average
expression level of the control BaF3 clones. Genes that were differentially
expressed upon ZFAT overexpression were selected using two independent
filteringmethods. One method was volcano plot filtering, in which the relative fold
change between the mean values of triplicates (three ZFAT-HA transformants and
three controls) and the statistical significance level (p value for a t test of difference
between the two groups) are considered. The other was the use ofVenn diagrams to
select genes that consistently exceed a designated threshold (2.0- or 1.5-fold
change) in all of three ZFAT-HA transformants compared to each of three controls.
Quantitative RT-PCR was performed using LightCycler and FastStart DNA
Master SYBR Green I (Roche). The thermal cycling conditions were initial
denaturation at 95°C 5 min, followed by up to 40 cycles of denaturation at 95°C
for 15 s, annealing at 62°C for 15 s, and extension at 72°C for 10 s. The PCR
primer sequences used for each of 24 genes are listed in Supplementary Table 5.
Absolute quantification was performed for each gene and for the β-actin gene as
the normalization standard. The fold change of the mean of three ZFAT-HA
transformants relative to that of three controls was determined.Acknowledgments
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